-
Medtronic receives FDA clearance for new InPen™ app, paving the way for its Smart MDI system launch with Simplera™ CGM
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration (FDA) clearance for its...
November 20, 2024
-
NVIDIA Announces Omniverse Real-Time Physics Digital Twins With Industry Software Leaders
NVIDIA today announced an NVIDIA Omniverse™ Blueprint that enables industry software developers to help their computer-aided engineering (CAE) customers in...
November 20, 2024
By: Traders on Trend
-
Target Corporation Reports Third Quarter Earnings
Target Corporation (NYSE: TGT) today announced its third quarter 2024 financial results, reflecting comparable sales growth driven entirely by traffic...
November 20, 2024
-
C3 AI and Microsoft Forge Strategic Alliance to Accelerate Enterprise AI Adoption
Today at Microsoft Ignite, C3 AI (NYSE: AI), the Enterprise AI application software company, and Microsoft Corp. (NASDAQ: MSFT) announced a strategic...
November 20, 2024
-
Progressive Insurance® Introduces Accident Response® to Customers Nationwide
Progressive Insurance® today announced the launch of its newest safety feature, Accident Response, to afford customers peace of mind and connect...
November 19, 2024
-
Illumina announces expansion of TruSight Oncology portfolio
Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that it will release TruSight™ Oncology...
November 19, 2024
-
Supermicro Delivers Direct-Liquid-Optimized NVIDIA Blackwell Solutions
Supercomputing Conference – Supermicro, Inc. (NASDAQ: SMCI), a Total IT Solution Provider for AI, Cloud, Storage, and 5G/Edge, is announcing the...
November 19, 2024
-
Walmart reports strong revenue growth of 5.5% with operating income growing faster at 8.2%
Walmart reports strong revenue growth of 5.5% with operating income growing faster at 8.2% eCommerce up 27% globally GAAP EPS...
November 19, 2024
By: Traders on Trend
-
Lumen Announces (1) Expiration and Results of Certain Previously-Announced Cash Tender Offers of Lumen and Level 3 and (2) Amendments to the Remaining Previousl
The Offers of Lumen and Level 3 to purchase any and all of their respective outstanding unsecured notes identified in...
November 19, 2024
-
Cardiol Therapeutics’ Phase II MAvERIC-Pilot Clinical Results in Recurrent Pericarditis Presented at the American Heart Association Scientific Sessions 2024
Toronto, Ontario–(Newsfile Corp. – November 18, 2024) – Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (“Cardiol” or the “Company“), a clinical-stage life...
November 18, 2024